Q4 2017 pSivida Corp Earnings Call

11/9/2017 16:30

Llamada en conferencia pSivida Corp

pSivida Corp Conference call or earnings call will be held on 11-sep-2017 During the earnings conference call's session pSivida Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact pSivida Corp for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We develop sustained-release drug delivery products primarily for the treatment of chronic eye diseases. Our products deliver drugs at a controlled and steady rate for months or years. We have developed three of only four sustained-release products approved by the United States (U.S.) Food and Drug Administration (FDA) for treatment of back-of-the-eye diseases. Medidur(TM) for posterior segment uveitis, our lead product candidate, is in pivotal Phase 3 clinical trials, and ILUVIEN® for diabetic macular edema (DME), our lead licensed product, is sold in the U.S. and three European Union (EU) countries. Our product development program is focused primarily on utilizing our two core technology platforms to deliver drugs and biologics to treat chronic diseases. Our strategy includes developing products independently while continuing to leverage our technology platforms through collaborations and license agreements as appropriate.    
Leer más Llamada en conferencia

pSivida Corp (PSDV)

480 Pleasant Street, Watertown Massachusetts 02472, United States